Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • Anda

    - PMLiVE

    Minds + Assembly Launches Assembled Intelligence and Adds Stratevi to Expand Market Access and HEOR Solutions

    New York, NY — 10.23.2025 — Minds + Assembly, a leading healthcare marketing firm, today announced the launch of Assembled Intelligence, an integrated communications and commercialization platform designed to unite...

    BOLDSCIENCE

    - PMLiVE

    FDA approves Alvotech and Teva’s Simlandi as interchangeable Humira biosimilar

    Simlandi is approved to treat multiple indications, including rheumatoid arthritis and Crohn’s disease

    - PMLiVE

    Sandoz separates from Novartis as an independent spin-off company

    The split allows Sandoz to strengthen its position in generics and biosimilars

    - PMLiVE

    Teva and Allergan finalise terms of US opioid settlements worth $6.6bn combined

    Nearly 500,000 died from an opioid overdose between 1999 and 2019

    - PMLiVE

    Sandoz launches generic oncology treatment in Europe

    Lenalidomide can be used to treat patients with haemato-onocology conditions, following recommendations from recent European Society for Medical Oncology (ESMO) guidelines

    - PMLiVE

    Teva reaches $925,000 settlement to resolve drug price-fixing claims

    Last year, the US Department of Justice charged Teva for conspiring with competitors in a generic drug price-fixing probe

    - PMLiVE

    Pfizer, Sanofi and others set to increase US drug prices in 2021

    Pressure from COVID-19 restrictions leads to drug price increases

    - PMLiVE

    US charges Teva for generic drug price-fixing plot

    Company maintains it has not committed any wrongdoing

    - PMLiVE

    FDA approves Allergan’s biodegradable glaucoma implant drug

    Reduces intraocular pressure in glaucoma or ocular hypertension

    - PMLiVE

    Allergan and Editas claim a CRISPR first in inherited blindness study

    Partners are first to use CRISPR to edit cells inside the body

    - PMLiVE

    Mergers and acquisitions: agents for change

    Getting the best from your agency in a disruptive time

    Bedrock Healthcare Communications

    - PMLiVE

    AbbVie says Allergan takeover delayed by FTC verdict

    Merger now likely to complete in second quarter rather than first

    Subscribe to our email news alerts

    Latest content

    Latest intelligence

    Quick links